EMA Authorised: Thyrogen (thyrotropin alfa) — Sanofi B.V.

View source ↗

Summary

The European Medicines Agency has authorised Thyrogen (thyrotropin alfa) for use in thyroid neoplasms. The marketing authorization holder is Sanofi B.V., with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Neoplasms

Drugs mentioned

• Thyrogen (thyrotropin alfa)

Snippet

Status: Authorised. Therapeutic area: Thyroid Neoplasms. MAH: Sanofi B.V.. Decision date: 13/01/2025